Ionis Pharmaceuticals Inc

IONS

Equity

ISIN null / Valor 30877188

NASDAQ (2026-02-26)

USD 80.60-0.41%

Ionis Pharmaceuticals Inc
UMushroom community rating:

3.00 1 votes No rating yet

NegativeNeutralPositive

About company

Ionis Pharmaceuticals Inc., headquartered in Carlsbad, California, is a biotechnology company specializing in the discovery and development of RNA-targeted therapeutics. Established in 1989, Ionis has pioneered the field of antisense technology, which involves designing drugs to bind to specific RNA molecules, thereby modulating the production of proteins associated with various diseases. The company has a robust pipeline of drugs targeting a range of conditions, including cardiovascular, neurological, and rare diseases. A notable product in their portfolio is TRYNGOLZA™ (olezarsen), which is aimed at treating conditions related to elevated triglycerides. Ionis operates independently in the U.S. market while leveraging strategic partnerships to expand its global reach. Additionally, its wholly-owned subsidiary, Akcea Therapeutics, focuses on developing and commercializing treatments for patients with serious and rare diseases. Ionis is publicly traded on the Nasdaq under the ticker symbol IONS.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

154%1Y

126%3Y

53.8%5Y

Performance

47.7%1Y

40.8%3Y

43.5%5Y

Volatility